The Conversation (0)
Cannabis Big News Roundup: Chemesis International Inc. Acquires Viverian CBD Product Catalogue; High Tide Closes its Previously Announced Acquisition of Grasscity; FSD Pharma Announces Strategic Investment in Huge Shops
Dec. 21, 2018 10:00AM PST
Cannabis Investing News
In case you missed it, here is this week’s big news roundup for cannabis.
In case you missed it, here is this week’s big news roundup for cannabis:
- Chemesis International Inc. Acquires Viverian CBD Product Catalogue
- Biome Grow receives new consumer sales amendment from Health Canada for its Nova Scotia brand, Highland Grow
- Heritage Completes Acquisition of Purefarma Solutions
- Cannvas MedTech To Join Global Cannabis Partnership As Member Organization
- Wayland Announces Significant Supply Agreement with RavenQuest BioMed
- High Hampton’s Mojave Jane Announces Start of Production in California January 2019
- Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader
- Flowr Expands into Global Markets by Acquiring 19.8% Of Large-Scale Portuguese and Australian Cannabis Producer Holigen
- High Tide Closes its Previously Announced Acquisition of Grasscity
- Yield Growth Signs Agreements to Sell Cannabis Topicals Through 400 Store Distribution Network in Oregon
- Invictus Signs Five-year 10,000 kg Supply Agreement With Deutsche Medizinalcannabis in Germany
- 1933 Industries Plans To Increase CBD Production Capacity in Las Vegas
- FSD Pharma Announces Strategic Investment in Huge Shops
- Isodiol International Inc. Announces Acquisition of Food Labs, Inc. and Strategic Investor Relationship with Toba Capital LLC
- Kalytera Provides Update on Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD
- Next Green Wave Announces Its U.S. Listing on OTCQB Under the Symbol NXGWF
To see our previous Cannabis Investing Big News Roundups, please click here.
